Your browser doesn't support javascript.
loading
Cancer-specific mortality of high-risk prostate cancer after carbon-ion radiotherapy plus long-term androgen deprivation therapy.
Kasuya, Goro; Ishikawa, Hitoshi; Tsuji, Hiroshi; Haruyama, Yasuo; Kobashi, Gen; Ebner, Daniel K; Akakura, Koichiro; Suzuki, Hiroyoshi; Ichikawa, Tomohiko; Shimazaki, Jun; Makishima, Hirokazu; Nomiya, Takuma; Kamada, Tadashi; Tsujii, Hirohiko.
Afiliación
  • Kasuya G; Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
  • Ishikawa H; Department of Radiation Oncology, Faculty of Medicine, Graduate School of Medicine, Tsukuba University, Ibaraki, Japan.
  • Tsuji H; Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
  • Haruyama Y; Department of Public Health, Dokkyo Medical University School of Medicine, Tochigi, Japan.
  • Kobashi G; Department of Public Health, Dokkyo Medical University School of Medicine, Tochigi, Japan.
  • Ebner DK; Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
  • Akakura K; Brown University Alpert Medical School, Providence, RI, Japan.
  • Suzuki H; Department of Urology, Japan Community Health Care Organization Tokyo, Shinjuku Medical Center, Tokyo, Japan.
  • Ichikawa T; Department of Urology, Toho University Sakura Medical Center, Chiba, Japan.
  • Shimazaki J; Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Makishima H; Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Nomiya T; Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
  • Kamada T; Kanagawa Cancer Center, Yokohama, Japan.
  • Tsujii H; Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
Cancer Sci ; 108(12): 2422-2429, 2017 Dec.
Article en En | MEDLINE | ID: mdl-28921785
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Radioterapia de Iones Pesados / Antagonistas de Andrógenos / Antineoplásicos Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2017 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Radioterapia de Iones Pesados / Antagonistas de Andrógenos / Antineoplásicos Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2017 Tipo del documento: Article País de afiliación: Japón